35 research outputs found
Antioxidant and Quinone Reductase-Inducing Constituents of Black Chokeberry (Aronia melanocarpa) Fruits
Using in vitro hydroxyl radical-scavenging and quinone
reductase-inducing
assays, bioactivity-guided fractionation of an ethyl acetate-soluble
extract of the fruits of the botanical dietary supplement, black chokeberry
(Aronia melanocarpa), led to the isolation
of 27 compounds, including a new depside, ethyl 2-[(3,4-dihydroxybenzoyloxy)-4,6-dihydroxyphenyl]
acetate (<b>1</b>), along with 26 known compounds (<b>2</b>ā<b>27</b>). The structures of the isolated compounds
were identified by analysis of their physical and spectroscopic data
([Ī±]<sub>D</sub>, NMR, IR, UV, and MS). Altogether, 17 compounds
(<b>1</b>ā<b>4</b>, <b>9</b>, <b>15</b>ā<b>17</b>, and <b>19</b>ā<b>27</b>) showed significant antioxidant activity in the hydroxyl radical-scavenging
assay, with hyperin (<b>24</b>, ED<sub>50</sub> = 0.17 Ī¼M)
being the most potent. The new compound (<b>1</b>, ED<sub>50</sub> = 0.44 Ī¼M) also exhibited potent antioxidant activity in this
assay. Three constituents of black chokeberry fruits doubled quinone
reductase activity at concentrations <20 Ī¼M, namely, protocatechuic
acid [<b>9</b>, concentration required to double quinone reductase
activity (CD) = 4.3 Ī¼M], neochlorogenic acid methyl ester (<b>22</b>, CD = 6.7 Ī¼M), and quercetin (<b>23</b>, CD
= 3.1 Ī¼M)
Pyrrole Alkaloids with Potential Cancer Chemopreventive Activity Isolated from a Goji Berry-Contaminated Commercial Sample of African Mango
Bioassay-guided fractionation of
a commercial sample of African
mango (Irvingia gabonensis) that was
later shown to be contaminated with goji berry (Lycium sp.) led to the isolation of a new pyrrole alkaloid, methyl 2-[2-formyl-5-(hydroxymethyl)-1<i>H</i>-pyrrol-1-yl]Āpropanoate, <b>1</b>, along with seven
known compounds, <b>2</b>ā<b>8</b>. The structures
of the isolated compounds were established by analysis of their spectroscopic
data. The new compound <b>1</b>g showed hydroxyl radical-scavenging
activity with an ED<sub>50</sub> value of 16.7 Ī¼M, whereas 4-[formyl-5-(methoxymethyl)-1<i>H</i>-pyrrol-1-yl]Ābutanoic acid (<b>2</b>) was active
in both the hydroxyl radical-scavenging (ED<sub>50</sub> 11.9 Ī¼M)
and quinone reductase-induction [CD (concentration required to double
QR activity) 2.4 Ī¼M)] assays used. The isolated compounds were
shown to be absent in a taxonomically authenticated African mango
sample but present in three separate authentic samples of goji berry
(Lycium barbarum) using LC-MS and <sup>1</sup>H NMR fingerprinting analysis, including one sample that previously
showed inhibitory activity in vivo in a rat esophageal cancer model
induced with <i>N</i>-nitrosomethylbenzylamine. Additionally,
microscopic features characteristic of goji berry were observed in
the commercial African mango sample
New Bioactive Lupane Triterpene Coumaroyl Esters Isolated from Buxus cochinchinensis
Five new lupane triterpene coumaroyl esters (1ā5), together with betulin (6) and a known Buxus alkaloid, N-3-benzoyldihydrocyclomicrophylline F (7), were isolated from a CHCl(3)-soluble partition of a methanol extract of Buxus cochinchinensis Pierre ex Gagnep. (Buxaceae) collected in Vietnam. Isolation work was monitored using human colon cancer cells (HT-29). The structures of the new compounds (1ā5) were determined on the basis of spectroscopic data interpretation. In addition to their cytotoxicity against HT-29 cells and NF-ĪŗB (p65) inhibitory activity in an ELISA assay, all isolates, as well as two semi-synthetic compounds derived from betulin and 5, respectively, were also evaluated for their in vitro antiplasmodial activities against the drug-resistant Dd2 strain of Plasmodium falciparum and antifungal effects on the growth of the pathogenic yeast Candida albicans. The new lupane triterpene coumaroyl esters (1ā5), along with a betulin derivative and the known Buxus alkaloid, were found to show significant in vitro antimalarial activities, with IC(50) values ranging from 0.26 to 2.07 ĀµM
Bioassay-Guided Isolation of Antioxidant and Cytoprotective Constituents from a Maqui Berry (<i>Aristotelia chilensis</i>) Dietary Supplement Ingredient As Markers for Qualitative and Quantitative Analysis
Bioassay-guided phytochemical investigation
of a commercially available
maqui berry (<i>Aristotelia chilensis</i>) extract used
in botanical dietary supplement products led to the isolation of 16
compounds, including one phenolic molecule, <b>1</b>, discovered
for the first time from a natural source, along with several known
compounds, <b>2</b>ā<b>16</b>, including three
substances not reported previously in <i>A. chilensis</i>, <b>2</b>, <b>14</b>, and <b>15</b>. Each isolate
was characterized by detailed analysis of NMR spectroscopic and HRESIMS
data and tested for their in vitro hydroxyl radical scavenging and
quinone-reductase inducing biological activities. A sensitive and
accurate LCāDAD-MS method for the quantitative determination
of the occurrence of six bioactive compounds, <b>6</b>, <b>7</b>, <b>10</b>ā<b>12</b>, and <b>14</b>, was developed and validated using maqui berry isolates purified
in the course of this study as authentic standards. The method presented
can be utilized for dereplication efforts in future natural product
research projects or to evaluate chemical markers for quality assurance
and batch-to-batch standardization of this botanical dietary supplement
component
Computer-Assisted Structure Elucidation of Black Chokeberry (<i>Aronia melanocarpa</i>) Fruit Juice Isolates with a New Fused Pentacyclic Flavonoid Skeleton
Melanodiol 4ā³-<i>O</i>-protocatechuate (<b>1</b>) and melanodiol (<b>2</b>)
represent novel flavonoid
derivatives isolated from a botanical dietary supplement ingredient,
dried black chokeberry (<i>Aronia melanocarpa</i>) fruit
juice. These noncrystalline compounds possess an unprecedented fused
pentacyclic core with two contiguous hemiketals. Due to having significant
hydrogen deficiency indices, their structures were determined using
computer-assisted structure elucidation software. The in vitro hydroxyl
radical-scavenging and quinone reductase-inducing activity of each
compound are reported, and a plausible biogenetic scheme is proposed